Vimarsana
Biggest News Aggregation in the World

Page 36 - Grant Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Grant Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Grant Date Today - Breaking & Trending Today

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01.07.2022 - CAMBRIDGE, Mass., June 30, 2022 (GLOBE NEWSWIRE) - Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2022 that were previously approved by the Compensation ...

Sarepta Therapeutics Announces Inducement Grants Under - Vimarsana News

Sarepta Therapeutics Announces Inducement Grants Under

CAMBRIDGE, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases,...

Bulletin from the Annual General Meeting in Oncopeptides AB (publ) - Vimarsana News

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)

STOCKHOLM, June 28, 2022 /PRNewswire/ -- The Annual General Meeting in Oncopeptides AB (publ) (ONCO) was held on Tuesday, 28 June 2022. At the Annual General Meeting, the following principal

Investegate |Motorpoint Group plc Announcements | Motorpoint Group plc: Awards granted under the Performance Share Plan - Vimarsana News

Investegate |Motorpoint Group plc Announcements | Motorpoint Group plc: Awards granted under the Performance Share Plan

Investegate announcements from Motorpoint Group plc, Awards granted under the Performance Share Plan

uniQure Inc.: uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

uniQure Inc.: uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, June 22, 2022(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that